MAM
Jenny Setnicker joins Casbaa as head of advertising development
MUMBAI: Casbaa has appointed Jenny Setnicker as head of advertising development.
Setnicker has more than 15 years of media industry experience with eight years at CNBC Asia in advertising sales and client content solutions. Before that she worked at Omnicom Group developing client sponsorships for Millsport LLC in New York. Prior to that, she was in Hong Kong as part of Star TV‘s programming and acquisitions team.
Setnicker will be based out of Singapore and will be responsible for marketing the benefits of multichannel advertising. She will also handle new investment in the development of data and actionable insights relevant to the multi-channel TV sector in all its forms along with promoting value proposition for pay TV to media agencies, clients and network owners.
Setnicker will also be in charge of promoting the best interests of the Casbaa advertising members – AETN All Asia Networks, BBC Worldwide, Discovery Networks Asia-Pacific, FOX One Stop Media, NBCUniversal, Sony Pictures Television, TrueVisions and Turner Broadcasting System Asia Pacific.
Casbaa CEO Simon Twiston said, “With her extensive knowledge and experience in this industry, the appointment of Jenny is another significant step in Casbaa‘s efforts to increase awareness of the power of advertising on multichannel TV.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
